Sales at the pharmaceutical company fell by a worse-than-expected 13 percent in the second quarter, and the strong pound also hurt growth.
By REUTERS, NY Times: Business
Wed, 07/23/2014 - 4:21am
Sales at the pharmaceutical company fell by a worse-than-expected 13 percent in the second quarter, and the strong pound also hurt growth.